Aurobindo Pharma (AUROPHARMA) Shareholding Pattern

NSE: AUROPHARMA • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 51.82%
FII Holding 13.94%
DII Holding 27.68%
Public Holding 5.36%
Total Shareholders 236,859
As of Dec 2025
View the latest shareholding pattern of Aurobindo Pharma (AUROPHARMA) including promoter, FII, DII, and public holdings. Track AUROPHARMA ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See Aurobindo Pharma P/B ratio trends)

Aurobindo Pharma (AUROPHARMA) Shareholding Summary

  • Promoter holding remains unchanged at 51.82% in Dec 2025
  • FII/FPI have decreased holdings from 14.21% to 13.94% in Dec 2025
  • DIIs have increased holdings from 27.60% to 27.68% in Dec 2025
  • Institutional investors have decreased holdings from 41.81% to 41.62% in Dec 2025
  • Public holding has increased from 5.25% to 5.36% in Dec 2025
  • Number of shareholders decreased from 247,662 to 236,859 in Dec 2025

AUROPHARMA Quarterly Ownership Changes

Quarter-over-quarter changes for Aurobindo Pharma from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
-0.27%
DII Holding Change
Sept 2025 to Dec 2025
+0.08%
Public Holding Change
Sept 2025 to Dec 2025
+0.11%

Aurobindo Pharma (AUROPHARMA) Quarterly Shareholding Trends

Visual breakdown of AUROPHARMA ownership distribution over time. Learn more about AUROPHARMA 52-week high low.

Promoter
FII
DII
Public
Government

Rising institutional holdings in AUROPHARMA often correlate with improved fundamentals. Check out Aurobindo Pharma value estimation.

Aurobindo Pharma (AUROPHARMA) Shareholding Data

Download complete AUROPHARMA ownership data for offline analysis. Discover Aurobindo Pharma quarterly financials.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 51.82% 13.94% 27.68% 0.00% 5.36% 1.19% 99.99% 236,859
Sept 2025 51.82% 14.21% 27.60% 0.00% 5.25% 1.13% 100.01% 247,662
Jun 2025 51.82% 14.37% 26.93% 0.00% 5.67% 1.20% 99.99% 272,208
Mar 2025 51.82% 15.33% 26.23% 0.00% 5.47% 1.15% 100.00% 269,323
Dec 2024 51.82% 16.29% 25.20% 0.00% 5.52% 1.17% 100.00% 257,962
Sept 2024 51.82% 16.59% 25.13% 0.00% 5.33% 1.13% 100.00% 248,488
Jun 2024 51.80% 16.73% 24.77% 0.00% 5.47% 1.23% 100.00% 238,622
Mar 2024 51.83% 18.02% 23.28% 0.00% 5.52% 1.36% 100.01% 244,575
Dec 2023 51.83% 0.00% 20.23% 0.00% 5.64% 22.29% 99.99% 241,944
Sept 2023 51.83% 0.00% 17.94% 0.00% 6.15% 24.07% 99.99% 259,638
Jun 2023 51.83% 0.00% 15.73% 0.00% 7.01% 25.42% 99.99% 293,214
Mar 2023 51.83% 0.00% 15.08% 0.00% 8.54% 24.54% 99.99% 343,617
Dec 2022 51.83% 0.01% 14.89% 0.00% 9.42% 23.85% 100.00% 369,828
Sept 2022 51.83% 0.00% 16.23% 0.00% 8.65% 23.29% 100.00% 358,459
Jun 2022 51.83% 0.00% 15.58% 0.00% 8.80% 23.79% 100.00% 359,684
Mar 2022 51.83% 0.00% 15.83% 0.00% 8.37% 23.97% 100.00% 338,639
Dec 2021 51.83% 0.00% 15.11% 0.00% 8.99% 24.07% 100.00% 341,568
Sept 2021 51.83% 0.00% 13.82% 0.00% 9.60% 24.74% 99.99% 329,940
Jun 2021 51.83% 0.00% 12.72% 0.00% 8.54% 26.91% 100.00% 243,315
Mar 2021 51.94% 0.00% 10.99% 0.00% 8.71% 28.36% 100.00% 232,634

AUROPHARMA promoter holding above 50% indicates strong insider confidence. Explore the AUROPHARMA stock price history for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 51.82% 13.94% 27.68% 0.00% 5.36% 1.19% 99.99% 236,859
Sept 2025 51.82% 14.21% 27.60% 0.00% 5.25% 1.13% 100.01% 247,662
Jun 2025 51.82% 14.37% 26.93% 0.00% 5.67% 1.20% 99.99% 272,208
Mar 2025 51.82% 15.33% 26.23% 0.00% 5.47% 1.15% 100.00% 269,323
Dec 2024 51.82% 16.29% 25.20% 0.00% 5.52% 1.17% 100.00% 257,962
Sept 2024 51.82% 16.59% 25.13% 0.00% 5.33% 1.13% 100.00% 248,488
Jun 2024 51.80% 16.73% 24.77% 0.00% 5.47% 1.23% 100.00% 238,622
Mar 2024 51.83% 18.02% 23.28% 0.00% 5.52% 1.36% 100.01% 244,575
Dec 2023 51.83% 0.00% 20.23% 0.00% 5.64% 22.29% 99.99% 241,944
Sept 2023 51.83% 0.00% 17.94% 0.00% 6.15% 24.07% 99.99% 259,638
Jun 2023 51.83% 0.00% 15.73% 0.00% 7.01% 25.42% 99.99% 293,214
Mar 2023 51.83% 0.00% 15.08% 0.00% 8.54% 24.54% 99.99% 343,617

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 51.82% 13.94% 27.68% 0.00% 5.36% 1.19% 99.99% 236,859
Dec 2024 51.82% 16.29% 25.20% 0.00% 5.52% 1.17% 100.00% 257,962
Dec 2023 51.83% 0.00% 20.23% 0.00% 5.64% 22.29% 99.99% 241,944
Dec 2022 51.83% 0.01% 14.89% 0.00% 9.42% 23.85% 100.00% 369,828
Dec 2021 51.83% 0.00% 15.11% 0.00% 8.99% 24.07% 100.00% 341,568

Year-over-year trends reveal long-term ownership shifts.

Understanding Aurobindo Pharma (AUROPHARMA) Shareholding Pattern

Aurobindo Pharma shareholding pattern reveals who owns AUROPHARMA stock and how ownership changes over time. High promoter stakes in AUROPHARMA often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your AUROPHARMA trades. AUROPHARMA cash flow statement

Combine AUROPHARMA ownership analysis with price movements and financial performance for a complete investment picture. (See AUROPHARMA dividend growth)